Skip to main content
Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
2.900
+0.030 (1.05%)
At close: Apr 24, 2024, 4:00 PM
3.010
+0.110 (3.79%)
After-hours: Apr 24, 2024, 6:35 PM EDT

Acasti Pharma Income Statement

Millions CAD. Fiscal year is Apr - Mar.
Year 202220212020201920182017201620152014
Revenue
000.2000000
Cost of Revenue
000.08000000
Gross Profit
000.12000000
Selling, General & Admin
8.289.786.668.465.033.072.721.562.73
Research & Development
9.975.564.1715.9729.3711.965.845.786.73
Other Operating Expenses
33.910.255.700-0000
Operating Expenses
52.1615.5916.5424.4434.4115.048.567.349.46
Operating Income
-52.16-15.59-16.42-24.44-34.41-15.04-8.56-7.34-9.46
Interest Expense / Income
0001.084.961.380.1300
Other Expense / Income
-0.18-5.123.26--00-2.52-8.2
Pretax Income
-51.97-10.47-19.68-25.51-39.37-16.42-8.68-4.82-1.26
Income Tax
-9.54-0.650000-0.100
Net Income
-42.43-9.82-19.68-25.51-39.37-16.42-8.59-4.82-1.26
Shares Outstanding (Basic)
762210000
Shares Outstanding (Diluted)
762210000
Shares Change
21.09%148.46%40.25%55.80%210.47%57.61%4.08%0.40%-
EPS (Basic)
-5.70-1.62-7.98-14.40-35.04-45.07-37.01-21.62-5.86
EPS (Diluted)
-5.70-1.62-7.98-14.40-35.04-45.07-37.01-21.62-5.86
Free Cash Flow
-15.93-17.23-14.39-23.27-25.32-16.76-10.52-5.23-5.52
Free Cash Flow Per Share
-2.14-2.81-5.82-13.21-22.39-46.02-45.49-23.55-24.96
Gross Margin
--61.22%------
Operating Margin
---8377.04%------
Profit Margin
---10039.80%------
Free Cash Flow Margin
---7340.82%------
EBITDA
-51.85-10.47-18.75-22.12-32.07-13-6.47-2.990.52
EBITDA Margin
---9568.37%------
Depreciation & Amortization
0.1200.922.322.332.042.091.831.78
EBIT
-51.97-10.47-19.68-24.44-34.41-15.04-8.56-4.82-1.26
EBIT Margin
---10039.80%------
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).